Le dépistage du cancer du poumon

Abstract

Several randomized trials have demonstrated that a low-dose thoracic CT scan screening strategy without contrast injection reduces both lung cancer mortality and overall mortality in a high-risk population. In France and Europe, several scientific societies have advocated for this screening to be performed in eligible individuals. In France, the eligibility criteria are: age between 50 and 75 years, a smoking history of more than 20 pack-years, either current smokers or those who have quit within the last 15 years. A pilot national initiative is expected to begin in 2025 in the form of a clinical trial. This trial will assess the feasibility of nationwide screening and address major questions such as the role of biomarkers, optimization of eligible population selection, and the contribution of Artificial Intelligence. 1877-1203/© 2024 SPLF. Published by Elsevier Masson SAS. All rights reserved.